Archives: Agenda
PANEL DISCUSSION Debating Ownership and Risk Sharing in Sponsor and Vendor Partnerships
- Exploring the meaning of risk sharing across roles
- Supporting balance between procurement and R&D priorities
- Strengthening partnership models through transparency
1 x Biopharma panel seat available
1 x Vendor panel seat available
PANEL DISCUSSION Choosing Where to Run Clinical Trials in 2027 and Balancing Speed, Quality and Access
- Comparing timelines and setup across the UK EU and other key regions
- Understanding trade-offs between speed cost quality and patient access
- Deciding how to prioritise regions based on trial type and strategy
1 x Biopharma panel seat available
1 x Vendor panel seat available
Session reserved for TFS Health Science
FOCUS SESSION + EXPERT COMMENTARY Evaluating China Expansion Strategies for Global Clinical Development
Understanding when China makes sense, when it doesn’t, and how to build a practical operational pathway
- Evaluating when China is the right fit for global development strategies
- Weighing the benefits, risks and timelines of China-linked studies
- Exploring Australia and other ICH-aligned pathways into the US market
- Comparing China, Australia and Central & Eastern Europe for trial execution
- Aligning clinical operations, CMC, manufacturing and quality strategies
- Sharing practical lessons from sponsors currently assessing China expansion
2 x Biopharma panel seats available
1 x Vendor panel seat available